254 related articles for article (PubMed ID: 9623725)
1. Regulation of HLA-DR and costimulatory B7 molecules in human thyroid carcinoma cells: differential binding of transcription factors to the HLA-DRalpha promoter.
Lahat N; Rahat MA; Sadeh O; Kinarty A; Kraiem Z
Thyroid; 1998 May; 8(5):361-9. PubMed ID: 9623725
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of HLA-DR gene expression induced by IFN-gamma in malignant melanoma cell lines.
Lee JL; Kim YH; Lee JM; Kim JD; Kim SJ; Park JH
Yonsei Med J; 1999 Feb; 40(1):30-9. PubMed ID: 10198604
[TBL] [Abstract][Full Text] [Related]
3. Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: opposite effects of interferon and methimazole.
Montani V; Shong M; Taniguchi SI; Suzuki K; Giuliani C; Napolitano G; Saito J; Saji M; Fiorentino B; Reimold AM; Singer DS; Kohn LD
Endocrinology; 1998 Jan; 139(1):290-302. PubMed ID: 9421427
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.
Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS
Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426
[TBL] [Abstract][Full Text] [Related]
5. Control of HLA-DR antigen expression by gamma-interferon: separate signal transduction mechanisms in malignant and nonmalignant human thyroid cells.
Lahat N; Sobel E; Kraiem Z
Cancer Res; 1993 Sep; 53(17):3943-7. PubMed ID: 8358721
[TBL] [Abstract][Full Text] [Related]
6. Correlation between HLA-DR expression and level of poly(ADP-ribose) synthetase in human thyroid carcinoma cells.
Shinohara M; Morisawa K; Ota K; Qu Z; Takeda K; Hashimoto K; Tomoda T; Kurashige T; Taniguchi T
Cell Mol Biol (Noisy-le-grand); 1997 Mar; 43(2):227-35. PubMed ID: 9130606
[TBL] [Abstract][Full Text] [Related]
7. IFN-mediated differential regulation of the expression of HLA-B7 and HLA-A3 class I genes.
Hakem R; Le Bouteiller P; Barad M; Trujillo M; Mercier P; Wietzerbin J; Lemonnier FA
J Immunol; 1989 Jan; 142(1):297-305. PubMed ID: 2535859
[TBL] [Abstract][Full Text] [Related]
8. Lymphokine regulation of HLA-DR gene expression in human thyroid cell monolayers.
Piccinini LA; Mackenzie WA; Platzer M; Davies TF
J Clin Endocrinol Metab; 1987 Mar; 64(3):543-8. PubMed ID: 3102542
[TBL] [Abstract][Full Text] [Related]
9. Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions.
Nagamatsu T; Schust DJ; Sugimoto J; Barrier BF
Hum Reprod; 2009 Dec; 24(12):3160-71. PubMed ID: 19729380
[TBL] [Abstract][Full Text] [Related]
10. Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression.
Balducci-Silano PL; Suzuki K; Ohta M; Saito J; Ohmori M; Montani V; Napolitano G; Shong M; Taniguchi SI; Pietrarelli M; Lavaroni S; Mori A; Singer DS; Kohn LD
Endocrinology; 1998 May; 139(5):2300-13. PubMed ID: 9564838
[TBL] [Abstract][Full Text] [Related]
11. Influence of the sequence variations of the HLA-DR promoters derived from human melanoma cell lines on nuclear protein binding and promoter activity.
Lee TJ; Kim SJ; Park JH
Yonsei Med J; 2000 Oct; 41(5):593-9. PubMed ID: 11079619
[TBL] [Abstract][Full Text] [Related]
12. Dual expression of human leukocyte antigen molecules and the B7-1 costimulatory molecule (CD80) on human melanoma cells after particle-mediated gene transfer.
Albertini MR; Emler CA; Schell K; Tans KJ; King DM; Sheehy MJ
Cancer Gene Ther; 1996; 3(3):192-201. PubMed ID: 8725884
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR alpha gene regulation in immortalized human thyroid cancer cells.
Neufeld DS; Lahat N; Graves P; Gillon-Peled M; Kraiem Z; Davies TF
Clin Immunol Immunopathol; 1993 May; 67(2):151-6. PubMed ID: 8519090
[TBL] [Abstract][Full Text] [Related]
14. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
Fenton RG; Turcovski-Corrales SM; Taub DD
J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
[TBL] [Abstract][Full Text] [Related]
15. Antigen presentation by interferon-gamma-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells.
Lombardi G; Arnold K; Uren J; Marelli-Berg F; Hargreaves R; Imami N; Weetman A; Lechler R
Eur J Immunol; 1997 Jan; 27(1):62-71. PubMed ID: 9021999
[TBL] [Abstract][Full Text] [Related]
16. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
[TBL] [Abstract][Full Text] [Related]
17. Costimulation of human CD4+ T cells with LFA-3 and B7 induce distinct effects on AP-1 and NF-kappa B transcription factors.
Parra E; Varga M; Sigvardsson M; Hedlund G; Kalland T; Leanderson T; Sjögren HO; Dohlsten M
J Immunol; 1995 Aug; 155(3):1132-40. PubMed ID: 7543515
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous expression of thyroid peroxidase and human leukocyte antigen-DR by human thyroid cells: modulation by thyrotropin, thyroid-stimulating antibody, and interferon-gamma.
Chiovato L; Lapi P; Mariotti S; Del Prete G; De Carli M; Pinchera A
J Clin Endocrinol Metab; 1994 Aug; 79(2):653-6. PubMed ID: 7913937
[TBL] [Abstract][Full Text] [Related]
19. Modulation of human leukocyte antigen and intracellular adhesion molecule-1 surface expression in malignant and nonmalignant human thyroid cells by cytokines in the context of extracellular matrix.
Miller A; Kraiem Z; Sobel E; Lider O; Lahat N
Thyroid; 2000 Nov; 10(11):945-50. PubMed ID: 11128721
[TBL] [Abstract][Full Text] [Related]
20. Lack of B7-1/BB1 and B7-2/B70 expression on thyrocytes of patients with Graves' disease. Delivery of costimulatory signals from bystander professional antigen-presenting cells.
Matsuoka N; Eguchi K; Kawakami A; Tsuboi M; Nakamura H; Kimura H; Ishikawa N; Ito K; Nagataki S
J Clin Endocrinol Metab; 1996 Nov; 81(11):4137-43. PubMed ID: 8923872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
